Natco Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2026 ,inter alia, to consider and approve Further to our earlier intimation ....

Date: August 11, 2026 BSE Limited National Stock Exchange of India Limited Corporate Relations Department Listing Department Phiroze Jeejeebhoy Towers Exchange Plaza, Plot No. C/1, G Block Dalal Street, Fort Bandra Kurla Complex, Bandra (East) Mumbai 400 001 Mumbai 400 051 Maharashtra, India Maharashtra, India Scrip Code: 524816 Symbol: NATCOPHARM Sub: Intimation of Board Meeting in terms of Regulation 29 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended, to consider raising of funds Ref: Earlier Board Meeting intimation dated August 6, 2026 Dear Sir/Madam, Further to our earlier intimation dated August 6, 2026, pursuant to Regulation 29 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended, this is to inform you that a meeting of the Board of Directors of the Company will be held on August 14, 2026 to consider and evaluate proposals for raising funds through issuance of equity shares or other securities, including by way of a public issue, preferential issue, rights issue, private placement(s), qualified institutions placement(s) and/or any combination thereof or any other method as may be permitted in accordance with provisions of applicable laws, subject to market conditions and receipt of regulatory, statutory and other approvals as may be required. Please take the above information on your record. Thanking you, Yours faithfully, For and behalf of Natco Pharma Limited Ch. Venkat Ramesh Company Secretary & Compliance Officer